Title: Clinical Applications and Precautions of Acitretin

The first paragraph: summary of content

Acitretin is a synthetic retinoic acid drug mainly used to treat severe psoriasis and other keratinization abnormalities. This article will start from itsPharmacological effects,Indications,Usage and dosage,adverse reactionsandManufacturerIt is expanded into five aspects, focusing on its clinical value and usage limitations to help patients and doctors use it rationally.

Paragraph 2: Pharmacological effects and indications

Acitretin A regulates epidermal cell differentiation and proliferation, inhibits inflammatory responses, and improves psoriasis skin lesions. itsCore indicationsIncluding generalized pustular psoriasis, erythrodermic psoriasis and severe psoriasis vulgaris. Due to the risk of teratogenesis, women of childbearing age need strict contraception, and it is not suitable for patients with mild symptoms.

Paragraph 3: Usage, dosage and course of treatment

The usual starting dose is 25-30 mg daily, and the maintenance dose can be reduced to 10-20 mg based on adjustment for efficacy and tolerability. Course of treatment requiredindividualization, usually lasts for several months, and liver function and blood lipids need to be monitored regularly. Abrupt discontinuation may lead to a rebound of the condition and the dose needs to be gradually reduced.

Paragraph 4: Adverse reactions and contraindications

Common side effects include dry skin, cheilitis, and abnormal liver function. In severe cases, osteoporosis or hypertriglyceridemia may occur.Absolutely tabooIncluding pregnancy, lactation and severe liver and kidney dysfunction. Sun exposure and excessive intake of vitamin A should be avoided during medication.

Paragraph 5: Summary and manufacturer information

Acitretin is an important treatment option for severe psoriasis, but the risk-benefit ratio needs to be rigorously evaluated. At present, domestic manufacturers includeChongqing Huabang Pharmaceutical(Trade name: Fangxi), etc., please see the table below for specific product information:

Quote sources:

1. "Chinese Psoriasis Diagnosis and Treatment Guidelines" (2023 Edition)
2. State Drug Administration drug instructions (approval date: 2022-05)
3. Expert consensus on retinoic acid drugs (Chinese Journal of Dermatology, 2021)